Are Medicines on TrumpRx Seeing a Boost in Prescriptions? The Data Suggests the Answer Is (Mostly) ‘No’

And the reality that MFN may mean poor access in Europe, not lower prices in the U.S., begins to sink in

Brian Reid

Mar 6, 2026